Is GBIO or EQR a better dividend investment in 2026?

GBIO currently yields 37.45% with a 5% 5-year dividend growth rate. EQR yields 5.87% with 5% growth. The better choice depends on your goal: GBIO offers higher current income.

What is the dividend yield difference between GBIO and EQR?

GBIO has a forward dividend yield of 37.45% ($2.00/share annually). EQR yields 5.87% ($3.47/share annually). The yield gap is 31.58 percentage points.

Home › Compare › GBIO vs EQR

GBIO vs EQR: Dividend Comparison 2026

GBIO yields 37.45% · EQR yields 5.87%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GBIO wins by $153.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

GBIO

● Live price

37.45%

Share price

$5.34

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$201.6K

Annual income

$32,248.55

Full GBIO calculator →

EQR

● Live price

5.87%

Share price

$59.15

Annual div

$3.47

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.8K

Annual income

$5,475.61

Full EQR calculator →

Portfolio growth — GBIO vs EQR

📍 GBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GBIO	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GBIO + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GBIO pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBIO

Annual income on $10K today (after 15% tax)

$3,183.52/yr

After 10yr DRIP, annual income (after tax)

$27,411.27/yr

EQR

Annual income on $10K today (after 15% tax)

$499.01/yr

After 10yr DRIP, annual income (after tax)

$4,654.27/yr

At 15% tax rate, GBIO beats the other by $22,757.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBIO + EQR for your $10,000?

GBIO: 50%EQR: 50%

100% EQR50/50100% GBIO

Portfolio after 10yr

$124.7K

Annual income

$18,862.07/yr

Blended yield

15.12%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

GBIO

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$5.25

-1.7% upside vs current

Range: $5.00 — $5.50

Altman Z

-9.1

Piotroski

1/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+18.9% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBIO buys

EQR buys

No recent congressional trades found for GBIO or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGBIOEQR

Forward yield	37.45% ✓	5.87%
Annual dividend / share	$2.00	$3.47 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$201.6K ✓	$47.8K
Annual income after 10y	$32,248.55 ✓	$5,475.61
Total dividends collected	$148.7K ✓	$23.0K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold
Analyst price target	$5.25	$70.35 ✓

Year-by-year: GBIO vs EQR ($10,000, DRIP)

Year	GBIO Portfolio	GBIO Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$14,445	$3,745.32	$11,380	$679.82	+$3.1K → GBIO
2	$20,513	$5,056.29	$13,014	$837.25	+$7.5K → GBIO
3	$28,659	$6,710.36	$14,961	$1,036.20	+$13.7K → GBIO
4	$39,427	$8,761.91	$17,297	$1,289.22	+$22.1K → GBIO
5	$53,452	$11,265.44	$20,121	$1,613.15	+$33.3K → GBIO
6	$71,468	$14,273.72	$23,561	$2,030.84	+$47.9K → GBIO
7	$94,307	$17,835.96	$27,783	$2,573.54	+$66.5K → GBIO
8	$122,904	$21,996.02	$33,013	$3,284.39	+$89.9K → GBIO
9	$158,298	$26,790.73	$39,547	$4,223.51	+$118.8K → GBIO
10	$201,627	$32,248.55	$47,791	$5,475.61	+$153.8K → GBIO

GBIO vs EQR: Complete Analysis 2026

GBIO — Stock

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Full GBIO Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this GBIO vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBIO vs SCHD GBIO vs JEPI GBIO vs O GBIO vs KO GBIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.